Skip to main content
Premium Trial:

Request an Annual Quote

Large Scale Biology s Q4 Revenues Drop, Losses Narrow Slightly

NEW YORK, Feb. 4 (GenomeWeb News) - Large Scale Biology today reported a 38 percent drop in fourth-quarter revenues, year over year, along with a drop in R&D spending and narrowed losses.

LSBC posted revenues of $621,000 for the quarter ended Dec. 31, 2003, down from $997,000 in the year-ago period.   

The company's net loss on a GAAP basis was $7.1 million, or $.28 per share, for the quarter, down slightly from $7.3 million, or $.29 per share, for the fourth quarter of 2002. A total of $2.2 million in charges was related to the closure of the company's Germantown, Md.-based fee-for-service proteomics business. LSBC said it was reevaluating this business in November.

LSBC spent $2.8 million on R&D in the fourth quarter of 2003, down from $4.4 million in the same period last year.

As of Dec. 31, 2003, the company had $7.7 million in cash and marketable securities.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.